• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

atricure

AtriCure announces first use of newest AtriClip device

April 10, 2025 By Sean Whooley

AtriCure today announced the first use of its newest AtriClip device for minimally invasive concomitant procedures. Doctors used the AtriClip PRO-Mini left atrial appendage (LAA) exclusion system following its FDA 510(k) clearance earlier this year. The company built its newest device on the existing AtriClip platform, preloaded with what the company says is the smallest […]

Filed Under: Cardiac Implants, Cardiovascular, Structural Heart Tagged With: atricure, AtriCure Inc.

AtriCure plans a surgical pulsed field ablation play

October 30, 2024 By Chris Newmarker

AtriCure (Nasdaq:ATRC) stock is up more than 16% today on news of plans to expand into pulsed field ablation, which has generated buzz as a potentially better AFib treatment. The Mason, Ohio–based company has carved out a strong niche in the surgical space. It’s technology portfolio includes the Isolator Synergy ablation clamp for treating AFib […]

Filed Under: Business/Financial News, Cardiovascular, Featured, MassDevice Earnings Roundup, Pulsed-Field Ablation (PFA), Wall Street Beat Tagged With: atricure

AtriCure launches new CryoSphere Max cryoablation probe

October 15, 2024 By Sean Whooley

AtriCure announced today that it launched the CryoSphere Max cryoablation probe. The launch comes about six months after the company launched its new CryoSphere+ cryoablation probe for the CryoIce platform. CryoSphere Max features a larger ball tip designed to optimize Cryo Nerve Block therapy (CryoNB). The new probe reduces freeze times by 50% when compared […]

Filed Under: Neurological, Pain Management Tagged With: atricure, AtriCure Inc.

AtriCure wins CE mark for EnCompass clamp device

October 2, 2024 By Sean Whooley

AtriCure announced that it received CE mark for the EnCompass clamp for cardiac tissue ablation procedures. Following CE mark approval, the company says European surgeons already performed the first series of cases with EnCompass. The system received FDA 510(k) clearance and launched in the U.S. in 2022. Mason, Ohio-based AtriCure designed EnCompass for the ablation […]

Filed Under: Cardiovascular, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: atricure, AtriCure Inc.

AtriCure touts first case with new FDA-cleared AtriClip Flex-Mini

August 27, 2024 By Sean Whooley

AtriCure today announced the first patient treated with its AtriClip Flex-Mini device. The AtriClip Flex-Mini device recently received FDA 510(k) clearance. Mason, Ohio-based AtriCure says it’s the smallest-profile left atrial appendage (LAA) device on the market. It builds upon the company’s AtriClip platform with ease of use and design simplicity for enhanced access and increased […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Structural Heart, Surgical Tagged With: atricure, AtriCure Inc.

AtriCure wins expanded CE mark for left atrial appendage device

August 22, 2024 By Sean Whooley

AtriCure announced today that it received an expanded indication for its AtriClip devices in Europe. The expanded indication covers patients at high risk of thromboembolism for whom left atrial appendage exclusion is warranted. Mason, Ohio-based AtriCure designed its AtriClip device to exclude and electrically isolate the LAA during cardiac surgery. LAA can cause blood clots […]

Filed Under: Cardiac Implants, Cardiovascular, Regulatory/Compliance, Structural Heart, Surgical Tagged With: atricure, AtriCure Inc.

AtriCure wins nod to sell AtriClip in China

July 23, 2024 By Sean Whooley

AtriCure announced today that its AtriClip system received approval from regulatory authorities in China. The National Medical Products Administration (NMPA) of China approved several models of the left atrial appendage (LAA) exclusion system. AtriCure designed the device to exclude and electrically isolate the LAA during cardiac surgery. LAA can cause blood clots in patients with […]

Filed Under: Cardiac Implants, Cardiovascular, Regulatory/Compliance, Structural Heart, Surgical Tagged With: atricure, AtriCure Inc.

AtriCure launches new cryoablation probe

April 18, 2024 By Sean Whooley

AtriCure announced today that it launched its new CryoSphere+ cryoablation probe for the CryoIce platform. CryoSphere+ leverages new insulation technology, reducing freeze times by 25% compared to the legacy CryoSphere device. The original CryoIce device first received FDA clearance in November 2018 and aided in more than 60,000 procedures to date. The CryoSphere+ device picked […]

Filed Under: Business/Financial News, Neurological, Pain Management Tagged With: atricure, AtriCure Inc.

AtriCure grows sales by 21% in Q4

February 16, 2024 By Sean Whooley

AtriCure shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast. Shares of ATRC fell 2.8% at $33.25 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 0.7%. The Mason, Ohio-based company posted losses of $9.8 million. That […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, MassDevice Earnings Roundup, Structural Heart, Wall Street Beat Tagged With: atricure, AtriCure Inc.

AtriCure management expects Street-beating Q4 sales

January 8, 2024 By Chris Newmarker

AtriCure today announced preliminary fourth-quarter revenue results that beat the expectations of Wall Street analysts. The Mason, Ohio–based developer of surgical tools for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management expects to report Q4 2023 revenue of $106.5 million, up 21% year-over-year. The consensus on The Street was $102.43 million. […]

Filed Under: Business/Financial News, Cardiovascular, MassDevice Earnings Roundup, Surgical, Wall Street Beat Tagged With: atricure, AtriCure Inc.

AtriCure adds J&J veteran to its board

January 4, 2024 By Sean Whooley

AtriCure (Nasdaq:ATRC) announced today that it appointed longtime Johnson & Johnson executive Shlomi Nachman to its board of directors. Nachman most recently served as company group chair within the Johnson & Johnson Medical Devices (now MedTech) business. He also joined the board of transcatheter aortic valve replacement technology developer JenaValve in September. “I am thrilled […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Structural Heart Tagged With: atricure, AtriCure Inc., Personnel Moves

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy